The landscape of global healthcare delivery is poised for a significant transformation, driven by an ambitious collaboration between Oracle Health, Cleveland Clinic, and G42. Announced on May 16, 2025, from Abu Dhabi, United Arab Emirates, this strategic partnership aims to construct an advanced AI-based platform designed to make healthcare more effective, scalable, and economically viable worldwide. This initiative, we believe, marks a pivotal moment for medical tourism and the broader international patient care sector.

At its core, this groundbreaking platform seeks to elevate patient care and optimize public health management by harnessing the power of artificial intelligence, sophisticated nation-scale data analytics, and intelligent clinical applications. The ultimate goal is to pioneer secure, highly scalable, and easily accessible care models that will profoundly enhance human health and longevity across diverse populations.

A Synergistic Foundation for Global Healthcare

This innovative platform is envisioned as the bedrock for an AI-powered healthcare hub, integrating the robust infrastructure of Oracle Cloud Infrastructure, the analytical prowess of Oracle AI Data Platform, and the comprehensive suite of Oracle Health applications. This technological backbone will be augmented by Cleveland Clinic’s globally recognized clinical expertise and G42’s cutting-edge capabilities in sovereign AI infrastructure, seamless health data integration, and advanced clinical AI models. From a strategic perspective, this amalgamation of strengths creates a formidable force, particularly relevant for international patients seeking quality of care from leading institutions.

Designed with the evolving demands of global populations in mind, the platform’s initial rollout will focus on the U.S. and the United Arab Emirates – two prominent healthcare destinations. This strategic choice underscores the partners’ commitment to delivering secure, scalable, and intelligent healthcare solutions that not only enhance patient outcomes and enable precision medicine but also facilitate a crucial shift from reactive treatment paradigms to proactive wellness tourism and preventative care. For medical tourism professionals, this shift towards proactive health management presents new opportunities for patient travel.

Revolutionizing Clinical and Operational Efficiency

Fully AI-enabled health systems are set to continuously analyze population and public health data in real-time, providing practitioners with invaluable clinical intelligence precisely at the point of care. This immediate access to insights will empower clinicians and public health administrators to gain a much deeper understanding of patient populations’ well-being on a large scale, identifying factors that contribute to disease progression and suboptimal outcomes. In our view, this capability is a game-changer for international patient care, allowing for highly personalized and data-driven treatment plans.

Furthermore, this platform will enable healthcare organizations to simultaneously improve the quality of care while significantly driving down operational costs. By equipping both clinical and operational executives with the necessary data, advanced analyses, and predictive capabilities, the initiative aims to enhance both patient and financial outcomes. This dual focus on quality and cost-efficiency is paramount for any healthcare destination looking to attract and retain international patients.

Accelerating Life Sciences Innovation

A critical aspect of this collaboration is its potential to usher in a new era of life sciences innovation. By effectively dismantling the traditional silos that have long separated clinical research from clinical care, the platform promises to streamline the entire R&D process. Providers will find it much easier to identify suitable candidates for clinical trials and enroll them in appropriate studies directly at the point of care. This integration is a significant advantage for cross-border healthcare, as it can offer international patients access to novel treatments earlier.

Concurrently, researchers will gain access to invaluable real-world data, enabling them to detect opportunities for therapeutic intervention more rapidly. This access will also facilitate close monitoring of the performance and effects of both existing and new therapies, thereby mitigating risks, bolstering patient safety, and ultimately accelerating the delivery of life-saving new treatments to market. This capability strengthens the appeal of these partners as a global healthcare leader and a premier healthcare destination for advanced medical interventions.

Visionary Leadership Perspectives

Leaders from the partnering organizations articulated the profound impact of this venture.

Larry Ellison, Oracle Executive Chairman and CTO, emphasized the urgent need for innovation, stating, “Aging populations, rising costs, and the complexity of care demand a complete reinvention of how healthcare is provided. Oracle’s AI Data Platform and suite of clinical applications can help us understand disease and population health in ways that fuel scientific breakthroughs, reduce the cost of care delivery, and improve patient care. Together with Cleveland Clinic and G42, we will deliver the modern tools providers need to help people live longer, healthier lives.”

Dr. Tom Mihaljevic, President and CEO, and Morton C. Mandel CEO Chair of Cleveland Clinic, highlighted the moral imperative behind the initiative, noting, “This venture represents a bold leap forward in our collective mission to transform how healthcare is delivered. As a leader in healthcare, it is a moral imperative to create solutions that benefit the health and wellness of people. An AI-enabled model of care could positively impact global health systems—a flagship example of how data-driven, tech-powered healthcare can deliver better outcomes, lower costs, and expand access worldwide.” This aspiration to expand access worldwide directly resonates with the goals of medical tourism and improving access for international patients.

Peng Xiao, Group CEO at G42, underscored the strategic nexus of technology and science, remarking, “At the intersection of life-saving science and transformative technology lies our greatest opportunity to redefine the future of health. This partnership between Cleveland Clinic, Oracle Health, and G42 signals the strength of the UAE–US technology corridor, and our shared resolve to build a new health intelligence fabric. Together, we are advancing a model of care defined by precision, sovereignty, equity, and longevity for all.” This highlights the growing significance of the UAE as a global healthcare destination.

The Strategic Impact on Global Healthcare and Medical Tourism

This partnership is poised to establish a new benchmark for public-private collaboration and data-driven innovation, promising to dramatically enhance healthcare outcomes while simultaneously making care more affordable and accessible. It is our professional opinion that Oracle, Cleveland Clinic, and G42 are collectively reshaping the future of health for generations to come, creating a more integrated and efficient global healthcare ecosystem.

The existing strong collaboration between G42 and Cleveland Clinic, notably through Cleveland Clinic Abu Dhabi, provides a solid foundation for this expanded partnership. The United Arab Emirates has consistently demonstrated its unwavering commitment to advancing healthcare delivery, exemplified by its decades-long partnership with Cleveland Clinic. This history of successful collaboration undoubtedly bolsters confidence in the new venture’s potential to significantly impact international patient care.

It is important to note that this collaboration between Cleveland Clinic, G42, and Oracle is currently based on a non-binding agreement. However, the depth of commitment and the strategic alignment of all parties suggest a powerful intent to proceed and deliver on these ambitious goals.

Partnering for Progress: Who They Are

  • G42: As a technology holding group, G42 stands as a global leader in pioneering visionary artificial intelligence solutions for a better future. Originating in Abu Dhabi and operating internationally, G42 champions AI as a transformative force across various industries, from molecular biology to space exploration, realizing exponential possibilities today. More information can be found at www.g42.ai.
  • Oracle: Oracle Corporation (NYSE: ORCL) provides integrated suites of applications alongside secure, autonomous infrastructure within the Oracle Cloud. NetSuite, a registered trademark of Oracle Corporation, was notably the first cloud company, ushering in the modern era of cloud computing. For further details, visit oracle.com.
  • Cleveland Clinic: This nonprofit multispecialty academic medical center, founded in Cleveland, Ohio, in 1921, integrates clinical and hospital care with robust research and education. Renowned for pioneering medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States, Cleveland Clinic consistently receives global recognition for its expertise and quality of care. With 82,600 employees worldwide, including over 5,786 salaried physicians and researchers, and 20,700 registered nurses and advanced practice providers representing 140 medical specialties, Cleveland Clinic operates a 6,728-bed health system. Its extensive network includes a 173-acre main campus near downtown Cleveland, 23 hospitals, and 280 outpatient facilities, with international locations in Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2024, Cleveland Clinic managed 15.7 million outpatient encounters, 333,000 hospital admissions and observations, and 320,000 surgeries and procedures. Patients seeking treatment arrived from every U.S. state and 112 countries, solidifying its status as a premier global healthcare destination for medical tourism and international patients. Visit clevelandclinic.org and follow updates at x.com/CleClinicNews.

Bottom Line for Medical Tourism and Global Healthcare

This strategic alliance represents a significant milestone in the evolution of global healthcare. For the medical tourism industry, the implications are profound:

  1. Enhanced Quality of Care: The AI-powered platform promises to deliver more precise diagnoses, personalized treatments, and proactive health management, elevating the standard of care available to international patients.
  2. Increased Accessibility: By driving down costs and improving efficiency, the initiative aims to make high-quality healthcare more accessible, potentially expanding the pool of individuals who can pursue cross-border healthcare options.
  3. Advanced Healthcare Destinations: The focused development in the U.S. and UAE will further solidify their positions as leading healthcare destinations, attracting patient travel for cutting-edge treatments and wellness tourism.
  4. Accelerated Innovation: The integration of clinical care and research will lead to faster development and deployment of new therapies, making these partners attractive for patients seeking advanced, experimental, or specialized treatments not available in their home countries.
  5. Data-Driven Patient Experience: International patient care will become more streamlined and efficient, leveraging real-time data for better patient outcomes and a more cohesive healthcare journey.

The news signal for this article was referred from: https://www.oracle.com/news/announcement/oracle-cleveland-clinic-g42-announce-strategic-partnership-to-launch-ai-based-global-healthcare-delivery-platform-2025-05-16/